
FTSE 100's Dividend Edge: A Rare Opportunity For U.S. Income Investors
So let's look at a chart:
In the last 10 years, the Dow has outperformed the U.K. index by 100%. In a nutshell, the Dow has compounded by roughly 7% while the FTSE hasn't compounded by much at all.
Should that be the case?
No – not if the dividend yield is a guide, because the dividend yield of the Dow is roughly half that of the FTSE 100. This suggests, in old-school thinking, that the FTSE's long-term pricing values its dividends at half the price of the Dow's. If you think of the FTSE in terms of income alone, the dividend yield should be half what it is, and the price should be double to match the level of the venerable Dow Jones.
Dividends have long since lost their position of investment primacy, but the logic of valuing a stock by its dividends still has currency, and such a divergence suggests that either the price of the high-priced one should fall, the price of the one with cheap dividends should rise, or both. However, before we muse on what to do, take a look at this:
I'm a fan of accelerating charts. Information flows like honey, so when a long-term trend kicks off, it takes time for it to get on a stable course. The 'penny dropping' produces an acceleration, and then you see a rocket or a nosedive, with momentum driving the repricing. I'm tempted to see such an acceleration in the FTSE 100.
So for the U.S. income investor looking for a crack at the FTSE uplift, there is the iShare MSCI UK ETF, which throws off a 3.8% dividend, and for the Brit there is the Core FTSE 100 Tracker.
The FTSE is a dollar hedge, which is likely why it's rallying. Interest rates down, dollar down – it's that simple.
Of course, it's no fun to invest in stodgy stocks when the bright lights of the MAG7 beckon. Look at that cheese on the wooden stage. That metal sculpture is pretty too– and oh that cheese is tempting, let's go…
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
25 minutes ago
- Yahoo
Cementos Argos SA (CMTOY) Q2 2025 Earnings Call Highlights: Strategic Moves and Market Challenges
Release Date: August 13, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Cementos Argos SA (CMTOY) achieved a significant milestone by completing the spinoff of its portfolio, becoming a pure player in the heavy business materials industry. The company reported a dividend yield of 18%, significantly higher than the industry average of 2%, enhancing shareholder value. Cementos Argos SA (CMTOY) made a strategic acquisition of a 60% stake in a major aggregates asset in the Caribbean, with plans to generate $100 to $150 million in additional EBITDA by 2030. The company was selected to be part of the FTSE4Good Index, demonstrating strong environmental, social, and governance practices. Cementos Argos SA (CMTOY) reported a consolidated EBITDA margin of 22% for the second quarter, driven by a consistent pricing strategy and efficiency initiatives. Negative Points The company experienced a challenging construction environment, with cement and mix volumes decreasing by 4.4% and 19.7% respectively. Higher than expected maintenance costs in the Cartagena plant and certain non-recurring expenses impacted financial performance. The Panamanian market continues to lag, with a 12% decrease in demand, affecting overall regional performance. Cementos Argos SA (CMTOY) faced lower exports from Honduras due to a kiln stoppage, impacting volumes in Guatemala. Financial expenses were higher compared to the first quarter, partly due to fees paid to financial institutions. Q & A Highlights Warning! GuruFocus has detected 9 Warning Sign with CMTOY. Q: What are the trends in the Colombian market for the second half of the year, and what is the outlook for exports? A: We are seeing positive dynamics in Colombia, with improved daily average sales starting in June. The consumer segment and new housing sales are performing well, with a 20% increase in sales expected in the second half. Local municipalities are deploying more infrastructure projects, indicating a better second half. Regarding exports, we have reduced capacity due to the shutdown of a wet kiln in Cartagena for environmental and cost reasons. Juan Esteban Cale, CEO Q: Could you provide more details about the cement industry in Colombia and potential catalysts for demand? A: Interest rates and inflation are key catalysts. As interest rates decrease, demand increases, particularly in the retail segment. Infrastructure projects at municipal and state levels, such as the tunnel de Too in Antioquia and a new project in Bogota, are expected to drive demand. Carlos Giusi, VP of the Colombia Division Q: What are the impacts of non-recurring items on net income, and should we expect more in the future? A: The adjustment in the second quarter was due to the optimization of operations, specifically the plant in Puerto Rico. We do not expect further adjustments from this operation, and it has no negative impact on cash flow. Felicia Istizabal, CFO Q: How much of the proceeds from the Summit sale were used for the new Caribbean platform acquisition, and why were financial expenses higher this quarter? A: A small portion of the proceeds was used for the Caribbean platform acquisition. The acquisition includes significant reserves and access to deep water ports. Financial expenses were higher due to fees paid to financial institutions, despite stable debt levels. Juan Esteban Cale, CEO and Felicia Istizabal, CFO Q: What is the expected timeline and CapEx for the new platform to generate $150 million in EBITDA by 2030? A: We expect to reach this EBITDA level over the next five years, with total capital needed well below $50 million. Felicia Istizabal, CFO For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.

Yahoo
25 minutes ago
- Yahoo
Vyome to leverage US-India ties to tackle $100B immuno-inflammatory market
-- U.S.-India focused clinical-stage pharmaceutical maker Vyome Holdings (Nasdaq: HIND) rang the opening bell at the NASDAQ on Friday, celebrating Indian Independence Day and its trading debut after a reverse merger with ReShape Lifesciences. Shares of HIND last traded at $13.15, down 16%. The company is targeting the immuno-inflammatory market in the US and globally, valued at $100 billion. "The HIND journey begins today, a journey in which anyone, anywhere in the world can now participate thanks to our stock being on Nasdaq," said Krishna Gupta, Chairman of Vyome. Co-founder Shiladitya Sengupta, who also serves as Associate Professor of Medicine at Harvard Medical School, pointed to the company's "very deep" innovation pipeline and access to talent in both the United States and India. On how the US-India tech and innovation pipeline positions the company for growth, Gupta exclusively told 'The company has a pipeline of clinical stage assets; for each, Vyome has a plan to unlock value over the next 12-24 months. The research is being done collaboratively across India and the US.' The company decided to go public via a reverse merger versus the traditional route because they 'felt like it would be an easier and more efficient path if we could find a very clean public shell, which we did,' Gupta added. 'We were confident that opening up access to our vision to the entire world was the way we wanted to build the company going forward.' The Chairman doesn't feel the recently strained U.S./India relationship related to tariffs and Russian oil will have a negative impact on the company. 'It hasn't, nor do we think the relationship will be strained much longer - it's crazy to think that may be a contrarian view at this specific moment,' Gupta said in response to a question about whether the strained U.S./India relationship impacts the company. 'This is the defining partnership of the times, and the US and India will remain friends and collaborators, particularly in innovation-related endeavors.' Related articles Vyome to leverage US-India ties to tackle $100B immuno-inflammatory market Opendoor stock jumps after CEO exit, retail activists claim win The race for sovereign AI is intensifying. Here's what you need to know Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
25 minutes ago
- Yahoo
Difficult to See Bessent Size Rate Cut: Kathy Jones
US Treasury Secretary Scott Bessent made his most explicit call yet for the Federal Reserve to execute a cycle of interest-rate cuts, suggesting the central bank's benchmark ought to be at least 1.5 percentage points lower than it is now. However, Schwab Center for Financial Research Chief Fixed Income Strategist Kathy Jones says it is difficult to make the case for a big cut unless they are looking for the economy to fall off a cliff. She speaks with Vonnie Quinn on "Bloomberg Markets."